| |
|
| |
| DETAILS |
|
The 2026 Innovations in Regulatory Science Summit will highlight the latest developments in regulatory science, with panels on artificial intelligence, early endpoints, FDA leaders, & biopharmaceutical company leaders. We will also host two exciting debates on key issues in regulatory science.
The goal of the summit is to stimulate discussion across sectors & to critically consider lessons learned & scientific issues that need addressing to expeditiously & safely advance the development, approval, & monitoring of medical products.
The summit will be held as a hybrid event at Robertson Auditorium at the Mission Bay Conference Center at UCSF, 1675 Owens St, San Francisco, CA. In person & virtual attendance options are available. Please visit https://cersisummit.eventbrite.com to register.
UCSF welcomes all participants to our events. If you need a reasonable accommodation to participate in this event because of a disability, please contact Jaime.Kenyon@ucsf.edu as soon as possible.
Panels:
Addressing barriers to drug development with artificial intelligence
Using early endpoints to accelerate drug development
FDA Leaders Forum
Biopharmaceutical Leaders
Debates & Discussions include:
Is It Time to Get Rid of Animal Testing?
Should Biosimilars Be Approved Based on Analytical Equivalence & RWE Data Follow-up?
|
|
|
|
|
|
|
|
